Divi's Lab.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE361B01024
  • NSEID: DIVISLAB
  • BSEID: 532488
INR
6,433.50
-37.1 (-0.57%)
BSENSE

Dec 05

BSE+NSE Vol: 59.18 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Lupin
Sun Pharma.Inds.
Divi's Lab.
Torrent Pharma
Dr Reddy's Labs
Aurobindo Pharma
Alkem Lab
Cipla
Zydus Lifesci.
Abbott India
Mankind Pharma
Why is Divis Laboratories Ltd ?
1
High Management Efficiency with a high ROE of 17.24%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of 9.86% and Operating profit at 5.38% over the last 5 years
4
The company has declared Positive results for the last 5 consecutive quarters
  • ROCE(HY) Highest at 20.94%
  • DPS(Y) Highest at Rs 30.00
  • NET SALES(Q) Highest at Rs 2,715.00 cr
5
With ROE of 16.1, it has a Very Expensive valuation with a 11.1 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 5.51%, its profits have risen by 35.4% ; the PEG ratio of the company is 1.9
6
High Institutional Holdings at 39.16%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
7
Market Beating performance in long term as well as near term
  • Along with generating 5.53% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Divi's Lab. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Divi's Lab. for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Divi's Lab.
5.54%
0.21
26.64%
Sensex
4.7%
0.40
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
9.86%
EBIT Growth (5y)
5.38%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.21
Sales to Capital Employed (avg)
0.67
Tax Ratio
23.18%
Dividend Payout Ratio
49.69%
Pledged Shares
0
Institutional Holding
39.16%
ROCE (avg)
27.54%
ROE (avg)
17.24%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
69
Industry P/E
34
Price to Book Value
11.05
EV to EBIT
59.40
EV to EBITDA
51.51
EV to Capital Employed
13.66
EV to Sales
16.67
PEG Ratio
1.94
Dividend Yield
0.47%
ROCE (Latest)
22.99%
ROE (Latest)
16.12%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
ROCE(HY)

Highest at 20.94%

DPS(Y)

Highest at Rs 30.00

NET SALES(Q)

Highest at Rs 2,715.00 cr

PBDIT(Q)

Highest at Rs 888.00 cr.

PAT(Q)

Highest at Rs 689.00 cr.

EPS(Q)

Highest at Rs 26.00

-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 3,261.00 cr

Loading Valuation Snapshot...
Here's what is working for Divi's Lab.
Net Sales - Quarterly
Highest at Rs 2,715.00 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 888.00 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 689.00 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 26.00
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Dividend per Share (DPS) - Annually
Highest at Rs 30.00
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (Rs)

Here's what is not working for Divi's Lab.
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 3,261.00 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Non Operating Income - Quarterly
Highest at Rs 145.00 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income